Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Sensitivity to specific sweeteners, such as stevia What This Could Mean for Food and Beverage Innovation Taken together, the research suggests a potential shift in sensory expectations among some consumers using GLP-1 therapies
Kevin Jones, MD, Medical Director Flow Wellness Hear from Dr
[1] [2] Clinical trial data from the SURPASS program (evaluating tirzepatide for type 2 diabetes) and the SURMOUNT trials (assessing weight management efficacy) did not identify respiratory symptoms as a frequent adverse event directly attributable to the medication itself
To fill those gaps, the researchers searched medical databases for randomized clinical trials published up to February 2025
Third-party purity testing (HPLC & MS) U.S.-based fulfillment Published COAs per lot View Supplier References Literature & Citations Khavinson VK, Bondarev IE, Butyugov AA
